The transaction also included the sale of MidEuropa-backed MediGroup, the leading private healthcare provider in Serbia, to the same buyer.

The transaction is still subject to regulatory approvals and is expected to be completed by the end of this year. According to media reports, Regina Maria was sold for around €1 billion.

Janne-Olli Järvenpää, CEO of Mehiläinen Group, said: “We have closely followed the company's development for years, and we are truly delighted with the opportunity for acquisition. Regina Maria's sister company MediGroup is also a leading player in its market with excellent quality.”

Fady Chreih, CEO of Regina Maria and Chairman of the Board of MediGroup, added: ”Mehiläinen's investment marks an extremely significant chapter in our network's history, and we are excited to step into this new stage, where we aim, together, to transform the European landscape of private healthcare, relying on strong management teams and an integrated vision."

As part of the deal terms, Regina Maria will maintain its current brand and management team.

Mehiläinen Group operates in five European countries. The group currently manages over 890 clinics and medical facilities, supported by a network of more than 37,000 healthcare professionals. 

Serving over 2.2 million clients annually, Mehiläinen Group reported a revenue of €2 billion in 2024, an 11.5% increase compared to the previous year.

Regina Maria has a network of over 11,000 employees and collaborators across the country. The healthcare network serves nearly 1 million subscribers and has approximately 13,000 corporate partners.

MediGroup has over 100 units and more than 2,500 employees. The combined revenue of Regina Maria and MediGroup exceeded €550 million in 2024.